Laura Guzman
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Journal: Expert opinion on investigational drugs
Published: July 30, 2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Journal: Expert opinion on investigational drugs
Published: July 30, 2026
Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.
Journal: Biochemical pharmacology
Published: February 24, 2026
A peripheral proteomic signature of Alzheimer's disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study.
Journal: Research square
Published: November 24, 2025
Targeting the liver-brain axis: Licochalcone A as a therapeutic agent against HFD-induced neurodegeneration.
Journal: Biochemical pharmacology
Published: October 24, 2025
Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation.
Journal: GeroScience
Published: September 08, 2025
B-rich colistin and B-pure colistin as novel strategies to increase the therapeutic window of polymyxin antibiotic therapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 15, 2025
Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity.
Journal: International journal of pharmaceutics
Published: April 27, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents.
Journal: Molecular psychiatry
Published: April 08, 2025
Colistin treatment causes neuronal loss and cognitive impairment via ros accumulation and neuronal plasticity alterations.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 12, 2024
Combining the zebrafish embryo developmental toxicity assay (ZEDTA) with hemoglobin staining to accelerate the research of novel antimalarial drugs for pregnant women.
Journal: International journal for parasitology. Drugs and drug resistance
Published: September 07, 2024
Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 31, 2024
Showing 1-12 of 12
Last Updated: 09/26/2026